Rodman & Renshaw Terminates Coverage of China Pharma Holdings

by Benzinga Staff
July 26, 2011 3:39 AM | 12 seconds read

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

Rodman & Renshaw terminated its coverage of China Pharma Holdings (NYSE: CPHI). The rating agency's last rating placed on the company's stock was Market Outperform with a price target of $6. On Monday, CPHI closed the day at $2.14.

20-Year Pro Trader Reveals His "MoneyLine"

Ditch your indicators and use the "MoneyLine". A simple line tells you when to buy and sell without the guesswork. It’s a line on a chart that’s helped Nic Chahine win 83% of his options buys. Here's how he does it.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: Analyst RatingsRodman and Renshaw

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.